Oracle Investment Management
Latest statistics and disclosures from Oracle Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are WGS, ARDX, BHVN, Teladoc Inc call, Novavax, and represent 85.32% of Oracle Investment Management's stock portfolio.
- Added to shares of these 10 stocks: Novavax, ARDX, TSHA, Teladoc Inc call, EWTX, DAWN, PSNL, Pfizer Inc option, ARKG, TEM.
- Started 8 new stock positions in TEM, Pfizer Inc option, DAWN, Novavax, EWTX, ARKG, HTZ, TSHA.
- Reduced shares in these 10 stocks: Novavax Inc call (-$5.5M), PLTR (-$5.4M), , TDOC, NVAX, KOID, WGS, Biohaven, Ardelyx Inc call, BDSX.
- Sold out of its positions in BDSX, CNC, KOID, NVAX, Novavax Inc call, PLTR.
- Oracle Investment Management was a net seller of stock by $-7.9M.
- Oracle Investment Management has $168M in assets under management (AUM), dropping by 4.92%.
- Central Index Key (CIK): 0001012622
Tip: Access up to 7 years of quarterly data
Positions held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 22 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Genedx Holdings Corp Com Cl A (WGS) | 68.5 | $115M | 885k | 130.06 |
|
|
| Ardelyx (ARDX) | 6.5 | $11M | +24% | 1.9M | 5.83 |
|
| Biohaven (BHVN) | 5.2 | $8.7M | +4% | 772k | 11.29 |
|
| Teladoc Health Call Call Option | 2.7 | $4.6M | +38% | 650k | 7.00 |
|
| Novavax Note 5.000%12/1 Call Option (Principal) | 2.4 | $4.0M | NEW | 600k | 6.72 |
|
| Ardelyx Call Call Option | 2.1 | $3.5M | -5% | 600k | 5.83 |
|
| Quidel Corp (QDEL) | 2.0 | $3.4M | 118k | 28.56 |
|
|
| Forian Ord (FORA) | 1.7 | $2.9M | 1.4M | 2.12 |
|
|
| Personalis Ord (PSNL) | 1.6 | $2.7M | +47% | 339k | 7.96 |
|
| Biohaven Call Call Option | 1.6 | $2.6M | -15% | 233k | 11.29 |
|
| Teladoc (TDOC) | 1.5 | $2.5M | -49% | 354k | 7.00 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.9 | $1.5M | NEW | 265k | 5.50 |
|
| Cava Group Ord (CAVA) | 0.6 | $1.0M | 17k | 58.69 |
|
|
| Edgewise Therapeutics (EWTX) | 0.6 | $952k | NEW | 38k | 24.82 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.6 | $932k | NEW | 100k | 9.32 |
|
| Pfizer Call Call Option | 0.4 | $623k | NEW | 25k | 24.90 |
|
| Ark Etf Tr Genomic Rev Etf (ARKG) | 0.3 | $565k | NEW | 20k | 28.97 |
|
| Sangamo Biosciences (SGMO) | 0.3 | $435k | +3% | 1.0M | 0.42 |
|
| Biogen Idec (BIIB) | 0.3 | $425k | 2.4k | 175.99 |
|
|
| Tempus Ai Cl A (TEM) | 0.2 | $384k | NEW | 6.5k | 59.05 |
|
| Tesla Motors (TSLA) | 0.1 | $225k | 500.00 | 449.72 |
|
|
| Hertz Global Hldgs Com New (HTZ) | 0.0 | $77k | NEW | 15k | 5.14 |
|
Past Filings by Oracle Investment Management
SEC 13F filings are viewable for Oracle Investment Management going back to 2010
- Oracle Investment Management 2025 Q4 filed Feb. 18, 2026
- Oracle Investment Management 2025 Q3 filed Nov. 19, 2025
- Oracle Investment Management 2025 Q2 filed Aug. 15, 2025
- Oracle Investment Management 2025 Q1 filed May 15, 2025
- Oracle Investment Management 2024 Q4 filed Feb. 14, 2025
- Oracle Investment Management 2024 Q3 filed Nov. 14, 2024
- Oracle Investment Management 2024 Q2 filed Aug. 14, 2024
- Oracle Investment Management 2024 Q1 filed May 15, 2024
- Oracle Investment Management 2023 Q4 filed Feb. 14, 2024
- Oracle Investment Management 2023 Q3 filed Nov. 14, 2023
- Oracle Investment Management 2023 Q2 filed Aug. 14, 2023
- Oracle Investment Management 2023 Q1 filed May 15, 2023
- Oracle Investment Management 2022 Q4 filed Feb. 14, 2023
- Oracle Investment Management 2022 Q3 filed Nov. 14, 2022
- Oracle Investment Management 2022 Q2 filed Aug. 15, 2022
- Oracle Investment Management 2022 Q1 filed May 16, 2022